Richard W. Dugan's most recent trade in Vanda Pharmaceuticals Inc was a trade of 59,225 Common Stock done . Disclosure was reported to the exchange on June 5, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Vanda Pharmaceuticals Inc | Richard W. Dugan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2025 | 59,225 | 177,454 (0%) | 0% | 0 | Common Stock | |
| Vanda Pharmaceuticals Inc | Richard W. Dugan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 37,578 | 37,578 | - | - | Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Richard W. Dugan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 May 2024 | 20,529 | 118,229 (0%) | 0% | 0 | Common Stock | |
| Vanda Pharmaceuticals Inc | Richard W. Dugan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 33,960 | 33,960 | - | - | Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Richard W. Dugan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jun 2023 | 17,307 | 97,700 (0%) | 0% | 0 | Common Stock | |
| Vanda Pharmaceuticals Inc | Richard W. Dugan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 24,707 | 24,707 | - | - | Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Richard W. Dugan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2022 | 12,006 | 80,393 (0%) | 0% | 0 | Common Stock | |
| Vanda Pharmaceuticals Inc | Richard W. Dugan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 4.15 per share. | 31 May 2022 | 15,000 | 74,887 (0%) | 0% | 4.2 | 62,250 | Common Stock |
| Vanda Pharmaceuticals Inc | Richard W. Dugan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 31 May 2022 | 15,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Richard W. Dugan | Director | Sale of securities on an exchange or to another person at price $ 9.85 per share. | 31 May 2022 | 6,500 | 68,387 (0%) | 0% | 9.9 | 64,052 | Common Stock |
| Vanda Pharmaceuticals Inc | Richard W. Dugan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 10,000 | 10,000 | - | - | Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Richard W. Dugan | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2021 | 5,000 | 59,887 (0%) | 0% | 0 | Common Stock | |
| Vanda Pharmaceuticals Inc | Richard W. Dugan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 7.11 per share. | 16 Feb 2021 | 15,000 | 60,641 (0%) | 0% | 7.1 | 106,650 | Common Stock |
| Vanda Pharmaceuticals Inc | Richard W. Dugan | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 16 Feb 2021 | 15,000 | 0 | - | - | Stock Option (Right to Buy) | |
| Vanda Pharmaceuticals Inc | Richard W. Dugan | Director | Sale of securities on an exchange or to another person at price $ 18.54 per share. | 16 Feb 2021 | 5,754 | 54,887 (0%) | 0% | 18.5 | 106,663 | Common Stock |